TP-58, a novel thienopyridine derivative, protects mice from concanavalin A-induced hepatitis by suppressing inflammation

Cellular Physiology and Biochemistry

Volumn 29, Issue 1-2, 2012, Pages 31-40

  Li, Yi ^a   Wang, Zhen Ling ^a   He, Fang ^a   Wu, Yang ^a   Huang, Wen ^a   He, Yang ^a   Tong, Qing Yi ^a   Wei, Yu Quan ^a   Qing, Yong ^a,b   Yang, Li ^a   Wu, Xiaohua ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

ConA; Hepatitis; Nuclear factor B; Proinflammatory cytokines; TP 58

Indexed keywords

AMINOTRANSFERASE; CONCANAVALIN A; DEXAMETHASONE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITROUS OXIDE; THIENOPYRIDINE DERIVATIVE; TP 58; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HEPATITIS; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY DISEASE; LIVER INJURY; LIVER PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; TREATMENT RESPONSE;

MURINAE; MUS;

EID: 84859835424     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000337584     Document Type: Article

References (34)

1. Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-2250. (Pubitemid 30081976)
2. Tiegs G, Hentschel J, Wendel A: A T celldependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992;90:196-203.
3. Schumann J, Wolf D, Pahl A, Brune K, Papadopoulos T, van Rooijen N, Tiegs G: Importance of Kupffer cells for Tcell-dependent liver injury in mice. Am J Pathol 2000;157:1671-1683.
4. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G: Concanavalin A-induced Tcell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995;21:190-198.
5. Koerber K, Sass G, Kiemer AK, Vollmar AM, Tiegs G: In vivo regulation of inducible NO synthase in immunemediated liver injury in mice. Hepatology 2002;36:1061-1069. (Pubitemid 35253421)
6. Zeng XX, Zheng RL, Zhou T, He HY, Liu JY, Zheng Y, Tong AP, Xiang ML, Song, XR Yang SY, Yu LT, Wei YQ, Zhao YL, Yang L: Novel Thienopyridine Derivatives as Specific Antihepatocellular Carcinoma (HCC) Agents: Synthesis, Preliminary Structure-activity Relationships, and in vitro Biological Evaluation. Bioorgan Med Chem Letters 2010;20:6282-6285.
7. Baldwin AS Jr: The NF-kappa B and I kappa B proteins: new discoveries and insights Ann Rev Immunol 1996;14:649-683 (Pubitemid 26130197)
8. Wang ZL, Wu XH, Song LF, Wang YS, Hu XH, Luo YF, Chen ZZ, Ke J, Peng XD, He CM, Zhang W, Chen LJ, Wei YQ: Phosphoinositide 3-kinase inhibitor ameliorates concanavalin Ainduced hepatic injury in mice Biochem Biophys Res Comm 2009;386:569-574
9. Williams AS, Topley N, Dojcinov S, Richards PJ, Williams BD: Amelioration of rat antigen-induced arthritis by liposomally conjugated methotrexate is accompanied by down-regulation of cytokine mRNA expression Rheumatology 2001;40:375-383
10. Hentze H, Gantner F, Kolb SA, Wendel A: Depletion of hepatic glutathione prevents death receptor-dependent apoptotic and necrotic liver injury in mice. Am J Pathol 2000;156:2045-2056. (Pubitemid 30641772)
11. Ahn KS, Moon KY, Lee J, Kim YS: Downregulation of NF-kappaB activation in human keratinocytes by melanogenic inhibitors. J Dermatol Sci 2003;31:193-201. (Pubitemid 36519153)
12. Nath J, Powledge A: Modulation of human neutrophil inflammatory responses by nitric oxide: studies in unprimed and LPSprimed cells. J Leuko Biol 1997;62:805-816. (Pubitemid 28015629)
13. Bozza M, Bliss JL, Maylor R, Erickson J, Donnelly L, Bouchard P, Dorner AJ, Trepicchio WL: Interleukin-11 reduces T-cell-dependent experimental liver injury in mice. Hepatology 1999;30:1441-1447.
14. Galun E, Axelrod JH: The role of cytokines in liver failure and regeneration: potential new molecular therapies. Biochim Biophys Acta 2002;1592:345-358. (Pubitemid 35284888)
15. Wolf AM, Wolf D, Rumpold H, Ludwiczek S, Enrich B, Gastl G, Weiss G, Tilg H: The kinase inhibitor imatinib mesylate inhibits TNF-production in vitro and prevents TNF-dependent acute hepatic inflammation. PNAS 2005;102:13622-13627. (Pubitemid 41420898)
16. Bao XQ, Liu GT: Induction of overexpression of the 27-and 70-kDa heat shock proteins by bicyclol attenuates concanavalin A-Induced liver injury through suppression of nuclear factorkappaB in mice. Molecular pharmacology 2009;75:1180-1188.
17. Liu P, Cheng H, Roberts TM, Zhao JJ: Targeting the phosphoinositide 3-kinase pathway in cancer. Nature Rev Drug Discov 2009;8:627-644.
18. Jernberg T, Payne CD, Winters KJ, Darstein C, Brandt JT, Jakubowski JA, Naganuma H, Siegbahn A, Wallentin L: Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. Eur Heart J 2006;27:1166-1173.
19. Kam PCA, Nethery CM: The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments. Anaesthesia 2003;58:28-35. (Pubitemid 36113325)
20. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A: Resistin, an Adipokine with Potent Proinflammatory Properties J Immunol 2005;174:5789-5795 (Pubitemid 40593223)
21. Hernandez Mendoza L, Molinari JL, Garrido E, Cortes I, Solano S, Miranda E, Tato P: The implantation of Taenia solium metacestodes in mice induces downmodulation of T-cell proliferation and cytokine production. Parasitol Res 2005;95:256-265. (Pubitemid 40379466)
22. Jo D, Liu D, Yao S, Collins RD, Hawiger J: Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nature Med 2005;11:892-898. (Pubitemid 41161123)
23. Fritsche G, Dlaska M, Barton H, Theurl I, Garimorth K, Weiss G: Nramp1 functionality increases inducible nitric oxide synthase transcription via stimulation of IFN regulatory factor 1 expression. J Immunol 2003;171:1994-1998. (Pubitemid 36966483)
24. Martin E, Nathan C, Xie QW: Role of Interferon Regulatory Factor 1 in induction of Nitric Oxide Synthase. J Exp Med 1994;180:977-984. (Pubitemid 24256610)
25. Asai S, Kimbara N, Tada T, Imai M, Campbell W, Okada H, Okada N: Procarboxypeptidase R Deficiency Causes Increased Lethality in Concanavalin A-Induced Hepatitis in Female Mice. Biol Pharm Bull 2010;33:1256-1259.
26. Harizi H, Chaabane F, Ghedira K, Chekir-Ghedira L: Inhibition of proinflammatory macrophage responses and lymphocyte proliferation in vitro by ethyl acetate leaf extract from Daphne gnidium Cell Immunol 2010;267:94-101
27. Bradham CA, Qian T, Streetz K, Trautwein C, Brenner DA, JJ: The Mitochondrial Permeability Transition Is Required for Tumor Necrosis Factor Alpha-Mediated Apoptosis and Cytochrome c Release. Mol Cell Biol 1998;18:6353-6364. (Pubitemid 28500525)
28. Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Gejyo F, Nakayama T, Taniguchi M: Augmentation of V14 Nkt cell-mediated cytotoxicity by interleukin 4 in an autucrine mechanism resulting in the development of concanavalin a-induced hepatitis. J Exp Med 2000;191:105-114. (Pubitemid 30043652)
29. Tak PP, Firestein GS: NF-βB: a key role in inflammatory diseases. J Clin Invest 2001;107:7.
30. Hoffmann F, Sass G, Zillies J, Zahler S, Tiegs G, Hartkorn A, Fuchs S, Wagner J, Winter G, Coester C, Gerbes AL, Vollmar AM: A novel technique for selective NFkappaB inhibition in Kupffer cells: contrary effects in fulminant hepatitis and ischaemia-reperfusion. Gut 2009;58:1670-1678.
31. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP: Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Inves 2005;115:56-65. (Pubitemid 40385505)
32. Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NFkappa B. Ann Rev Cell Biol 1994;10:405-455.
33. Yang SQ, Lin HZ, Mandal AK, Huang J, Diehl AM: Disrupted signaling and inhibited regeneration in obese mice with fatty livers: Implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 2001;34:694-706. (Pubitemid 32927993)
34. Morwick T, Berry A, Brickwood J, Cardozo M, Catron K, DeTuri M, Emeigh J, Homon C, Hrapchak M, Jacober S, Jakes S, Kaplita P, Kelly TA, Ksiazek J, Liuzzi M, Magolda R, Mao C, Marshall D, McNeil D, Prokopowicz A, Sarko C, Scouten E, Sledziona C, Sun A, Watrous J, Wu JP, Cywin CL: Evolution of the Thienopyridine Class of Inhibitors of IβB Kinase-β: Part I: Hit-to-Lead Strategies. J Med Chem 2006;49:2898-2908.